While a shortage of marijuana is expected to precede any glut by a number of years, the potential for cannabis commoditization is already a consideration for many licensed cultivators in Canada. Greg Engel, CEO of New Brunswick-based Organigram, said commoditization, at least as it relates to cannabis, boils down to two things: Excess supply over […]Read More
Canada’s market leader in medical marijuana has applied to trade its shares on the New York Stock Exchange, a move that would make it the first cannabis-producing company to list on the world’s largest stock market.
Smiths Falls, Ontario-based Canopy Growth said in a news release it expects its shares to begin trading on the NYSE “before the end of May” under the symbol CGC.Read More
Two Senate committees reviewing Canada’s proposed marijuana legislation are asking for significant changes to the bill before it becomes law – changes that could delay implementation and have a major impact on businesses prepping for the recreational market.
The Committee on Aboriginal Peoples wants the bill amended to address a “lack of meaningful consultation” with First Nations communities and asked for a delay of up to one year.Read More
A Toronto-based marijuana company focused on U.S. recreational and medical cannabis markets plans to spend about 23 million Canadian dollars ($18.3 million) in cash, stock and warrants to acquire a small licensed producer in Ontario. MPX Bioceutical agreed to acquire Peterborough-based Canveda for CA$3 million in cash, CA$15 million in stock plus the issuance of 6 […]Read More
One of Canada’s top licensed producers unveiled plans for its largest cultivation facility, with a “significant proportion” of the new production slated to address a “massive” supply shortfall for medical cannabis overseas. Aurora Cannabis plans to build the 1.2-million-square-foot facility in Medicine Hat, Alberta, to take advantage of the “sunniest city in Canada” and save […]Read More
Exports of medical cannabis oil from Canada had a breakout year in 2017 – and executives say it is just the start for a massive new overseas market.
Medical cannabis exports in oil form rose 300% from 2016 levels, according to data shared with Marijuana Business Daily by Health Canada. Analysts expect this trend to continue as countries legalizing medical cannabis look to imports to meet demand in lieu of domestic cultivation.Read More
Canada’s medical cannabis companies have raised 2 billion Canadian dollars ($1.57 billion) in capital this year to tap overseas opportunities and build out domestic capacity ahead of legalization. While independent investment banks were involved in most of the transactions, the Bank of Montreal, through its subsidiary BMO Capital Markets, became the first major bank to lead […]Read More
Canadian cannabis stocks are down over 40% since peaking in early January, leading analysts to speculate about what might ultimately trigger a rebound. The Canadian Marijuana Index, a basket of the leading cannabis stocks operating in Canada, is 40% off its peak, or a loss of nearly 15 billion Canadian dollars ($12 billion) in market […]Read More
The chief executive of one of Canada’s largest banks said it would weigh financing cannabis companies after legalization takes place later this summer. TD Bank CEO Bharat Masrani said the Toronto-based financial institution is studying the issue, and any potential clients in the cannabis industry should have a presence only in countries where recreational or […]Read More
A German court slammed the brakes on the country’s plan to grant contracts to cultivate medical marijuana, giving international exporters an even bigger head start over domestic production as the country struggles to meet MMJ demand.
A representative for the Higher Regional Court of Dusseldorf told Marijuana Business Daily that the Federal Institute for Drugs and Medical Devices (BfArM) is not allowed to appeal the decision.Read More
Australia’s second-most populous state will explore international developments around “cannabis for adult use” as part of its investigation into drug law reform. In a 586-page report, a parliamentary committee in Victoria recommended the creation of a council to investigate global changes in marijuana usage, as well as several other considerations involving comprehensive drug law reform. […]Read More
Licensed producer Cronos Group is looking to raise up to 100 million Canadian dollars ($78 million) in what would be only the second equity financing between one of Canada’s biggest banks and a medical marijuana company. Cronos plans to spend CA$15 million of the new proceeds on capital expenditures related to international operations and domestic […]Read More
Until March ’21 Paid Ticket Holders Can Still:
- View every session on-demand
- Network and set up meetings
- Visit exhibitor showrooms
Thank you to all our sponsors, speakers, partners and attendees who made MJBizCon 2020 such a success!
Sign-Up here to be the first to know about our 2021 events
- SciPhy Systems & Artisan Industries Inc. announce the ARTISAN X-SR200: The next generation of solvent recovery systems for industrial hemp processingJanuary 14, 2021December 9, 2020November 16, 2020
- October 15, 2020Burns & Levinson hosts fourth annual state of the cannabis industry conference virtually on October 29, 2020October 14, 2020October 12, 2020
- September 22, 2020September 17, 2020September 11, 2020September 10, 2020
- January 22, 2021January 21, 2021January 21, 2021January 19, 2021
- January 19, 2021January 19, 2021January 19, 2021January 18, 2021January 15, 2021
- January 14, 2021January 13, 2021January 13, 2021
- January 22, 2021January 22, 2021January 22, 2021January 21, 2021January 21, 2021
- January 20, 2021January 18, 2021January 14, 2021January 13, 2021January 12, 2021
- January 12, 2021January 7, 2021